Literature DB >> 22349535

[Veno-arterial ECMO as bridge to recovery. Cardiogenic shock and suspected myocarditis in a 37-year-old patient].

H Fox1, F H Seeger, J Schmitt, M Potente, O Dzemali, S Fichtlscherer, J R Ehrlich.   

Abstract

We report a case of a 37-year-old patient presenting with fulminant cardiogenic shock, almost noncontractile ventricles, followed by electromechanical dissociation. During performance of cardiopulmonary resuscitation, a veno-arterial extracorporeal membrane oxygenation device (VA ECMO) was implanted, which became necessary for 13 days. Subsequently, a total arrest of ventricular function was observed and prominent multiple organ failure emerged. A rapid test for respiratory syncytial virus was positive, supporting the suspected diagnosis of myocarditis. Despite numerous complications, complete recovery was achieved.

Entities:  

Mesh:

Year:  2012        PMID: 22349535     DOI: 10.1007/s00063-011-0064-z

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  11 in total

Review 1.  Myocarditis.

Authors:  A M Feldman; D McNamara
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

2.  Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.

Authors:  R E McCarthy; J P Boehmer; R H Hruban; G M Hutchins; E K Kasper; J M Hare; K L Baughman
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

3.  Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years.

Authors:  N G Smedira; N Moazami; C M Golding; P M McCarthy; C Apperson-Hansen; E H Blackstone; D M Cosgrove
Journal:  J Thorac Cardiovasc Surg       Date:  2001-07       Impact factor: 5.209

4.  The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology.

Authors:  Leslie T Cooper; Kenneth L Baughman; Arthur M Feldman; Andrea Frustaci; Mariell Jessup; Uwe Kuhl; Glenn N Levine; Jagat Narula; Randall C Starling; Jeffrey Towbin; Renu Virmani
Journal:  Circulation       Date:  2007-10-24       Impact factor: 29.690

5.  Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution.

Authors:  S Nand; W Wong; B Yuen; A Yetter; E Schmulbach; S Gross Fisher
Journal:  Am J Hematol       Date:  1997-09       Impact factor: 10.047

6.  Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults.

Authors:  Ravi R Thiagarajan; Thomas V Brogan; Mark A Scheurer; Peter C Laussen; Peter T Rycus; Susan L Bratton
Journal:  Ann Thorac Surg       Date:  2009-03       Impact factor: 4.330

7.  Emergency use of extracorporeal membrane oxygenation in cardiopulmonary failure.

Authors:  Matthias Arlt; Alois Philipp; Markus Zimmermann; Sabine Voelkel; Matthias Amann; Thomas Bein; Thomas Müller; Maik Foltan; Christof Schmid; Bernhard Graf; Michael Hilker
Journal:  Artif Organs       Date:  2009-09       Impact factor: 3.094

Review 8.  [Myocarditis].

Authors:  H-P Schultheiss; U Kühl
Journal:  Dtsch Med Wochenschr       Date:  2008-12-15       Impact factor: 0.628

Review 9.  [State of diagnostics and therapy of inflammatory cardiomyopathie].

Authors:  H P Schultheiss; U Kühl
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

Review 10.  [Tako-Tsubo-cardiomyopathy].

Authors:  H M Nef; H Möllmann; P Hilpert; C Hamm; A Elsässer
Journal:  Dtsch Med Wochenschr       Date:  2008-08       Impact factor: 0.628

View more
  3 in total

1.  Noninvasive pulse contour analysis for determination of cardiac output in patients with chronic heart failure.

Authors:  Sebastian Roth; Henrik Fox; Uwe Fuchs; Uwe Schulz; Angelika Costard-Jäckle; Jan F Gummert; Dieter Horstkotte; Olaf Oldenburg; Thomas Bitter
Journal:  Clin Res Cardiol       Date:  2018-01-19       Impact factor: 5.460

2.  Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare Case.

Authors:  Henrik Fox; Martin Farr; Dieter Horstkotte; Christian Flottmann
Journal:  Case Rep Cardiol       Date:  2017-07-12

3.  Respiratory Syncytial Virus Associated Myocarditis Requiring Venoarterial Extracorporeal Membrane Oxygenation.

Authors:  Anamaria Milas; Aditya Shah; Neesha Anand; Meghan Saunders-Kurban; Samir Patel
Journal:  Case Rep Infect Dis       Date:  2017-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.